The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

25 Aug 2020 07:00

RNS Number : 0176X
Catenae Innovation PLC
25 August 2020
 

 

 25 August 2020

 

Catenae Innovation PLC

 

("Catenae", the "Company" or the "Group")

 

Business Update

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology provides the following business update.

 

Company Technology IP Development

 

Further to the announcement of 1 July 2020 regarding completion of the Cov-ID app and subsequent announcement on 3 July 2020 regarding completion of the Onsite ID app, the Company is pleased to provide the following product update.

 

In order to provide a more comprehensive product offering to cater for the needs of multiple sectors, Catenae has focused on upgrading its Onsite ID app to deliver an enhanced version of the Cov-ID app. Onsite ID allows multiple health and other work-related documents to be filed in a multi-document digital wallet and passport, and can therefore be used across a range of sectors including healthcare, construction and hospitality.

 

The Company now includes Data Dashboarding as part of the service that it offers its clients. The presentation of data sets within an easy-to-use, instant access dashboard on mobile devices gives business managers the ability to see the health and availability to work status of their workforces and to make fast business decisions ensuring efficient and productive workflows are maintained in the face of Covid-19.

 

Newcastle Premier Health Covid-19 Screening Programme

 

The Company announces the first commercial use of its Onsite ID app in partnership with its occupational health and wellness partner, Newcastle Premier Health Limited ("NPH").

 

NPH has completed the initial screening phase of its Access Control Programme for its customers. Onsite ID performs an integral part of the overall programme that helps businesses get employees back to work safely. Individual Covid-19 test results are set to be entered into the Onsite ID app which then will be used as a digital passport, enabling the users to share their Covid-19 status in a secure, immutable and GDPR compliant manner when meeting clients in person.

 

NPH's Access Control Programme is currently in progress and is expected to complete in the next three weeks. This will provide the Company with a useful case study for further sales and marketing activities.

 

Guy Meyer, Chief Executive Officer of Catenae, said: "We are pleased to have secured our first commercial sale for the Onsite ID app which has just undergone a version upgrade. This sale is testament to the app's effectiveness in managing workforces and providing safety in controlled environments, given its multi-purpose functionality. Our human-focused technologies are designed to mitigate risks for businesses, their people and their customers and I am pleased to see our latest product performing well in these challenging times.

 

"We remain focused on delivering results through building the Company's IP and talent capacity across the business as we further explore international and local sales opportunities, including those with NPH. We look forward to keeping the market updated with our progress."

 

Mark Philpott, Managing Director of NPH, commented: "NPH Group is now working with two new companies in the North East in the Finance and Manufacturing sectors to help them return their staff to work in a safe and supported way.

 

"Combined with Catenae's products, NPH's clinical solutions provide our clients with the ability to test, track and trace employees. Clients will also have the option to monitor the profile of a work population using dashboarding, making it easy for businesses to dynamically manage the risk profile and cycle of Covid-19 incidences, infection and testing. 

 

"We are excited to be at the forefront of providing solutions to businesses, helping them to move forward with confidence."

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Chief Executive Officer of the Company.

 

- Ends -

 

For further information please contact:

 

Catenae Innovation PLC

+44 (0)191 580 8545

Guy Meyer, Chief Executive Officer

Cairn Financial Advisers LLP (Nominated Adviser)

+44(0)20 7213 0880

Liam Murray / Jo Turner

Brandon Hill Capital Limited, Broker

+44 (0)20 3463 5000

Andy Gutmann

Yellow Jersey PR (PR & IP)

+44 (0)20 3004 9512

Sarah Hollins / Annabel Atkins

 

Notes to Editors:

 

About Catenae Innovation PLC

 

Catenae Innovation is an AIM quoted provider of digital media and technology services. Catenae use the power of blockchain to deliver solutions where its people-centric technology enables trust and certainty allowing organisations to gain better control over their operations, manage staff and safely welcome customers.

 

www.catenaeinnovation.com

 

Forward-Looking Statements

 

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.

 

 

 

The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFFATDISFII
Date   Source Headline
1st Jul 20203:12 pmRNSTotal Voting Rights
1st Jul 20202:06 pmRNSSecond Price Monitoring Extn
1st Jul 20202:00 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSCompletion of Cov-ID Project
30th Jun 20207:01 amRNSHalf-year Report
30th Jun 20207:00 amRNSFinal Results
26th Jun 20204:30 pmRNSExercise of Warrant
23rd Jun 20204:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20204:36 pmRNSPrice Monitoring Extension
19th Jun 20207:00 amRNSCov-ID Project Update
12th Jun 20209:58 amRNSIssue of Equity
11th Jun 20202:02 pmRNSShare Price Movement and Update
10th Jun 202012:30 pmRNSExercise of Warrant, Conversion & Issue of Equity
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
29th May 202012:24 pmRNSHolding(s) in Company
29th May 20207:00 amRNSAgreement with Newcastle Premier Health Ltd
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
21st May 20207:00 amRNSExercise of Warrant and Issue of Equity
18th May 20207:00 amRNSCov-ID Project Update
14th May 202012:49 pmRNSResult of General Meeting and Issue of Equity
1st May 20209:00 amRNSUpdate - Cov-ID Project
29th Apr 20205:09 pmRNSPosting of Circular and Notice of General Meeting
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSDirectorate Changes
23rd Apr 202012:19 pmRNSHolding(s) in Company
21st Apr 20202:05 pmRNSSecond Price Monitoring Extn
21st Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 20203:32 pmRNSConditional Placing to raise £320,000 and Update
17th Apr 20207:00 amRNSCatenae joins Consortium on Cov-ID Project
16th Apr 20205:30 pmRNSChange of Broker
31st Mar 20202:45 pmRNSHolding(s) in Company
31st Mar 20202:40 pmRNSHolding(s) in Company
31st Mar 20202:35 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNSAnnual Report, Trading & COVID-19 Update
26th Mar 202012:49 pmRNSWorking Capital Facility
31st Jan 20201:36 pmRNSIssue of Equity & Proposed Directorate Change
24th Jan 20201:20 pmRNSUpdate re Working Capital & Balance Sheet
10th Jan 202012:23 pmRNSUpdate re Working Capital & Balance Sheet
23rd Dec 201911:37 amRNSResult of General Meeting
20th Dec 20195:02 pmRNSUpdate re Working Capital
20th Dec 20191:23 pmRNSFurther re Share Capital & Timetable Update
20th Dec 20197:00 amRNSShare Capital and Total Voting Rights
19th Dec 20197:00 amRNSFurther re Agreements and update
6th Dec 201910:53 amRNSPosting of Circular and Notice of General Meeting
12th Sep 201910:50 amRNSHolding(s) in Company
11th Sep 20197:30 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.